Clopitab A 150mg Capsule

Clopitab A 150mg Capsule is a powerful dual antiplatelet therapy (DAPT) used to prevent serious cardiovascular events such as heart attack, stroke, and blood clot formation in patients with coronary artery disease, peripheral vascular disease, or after procedures like angioplasty and stent placement.

• Aspirin (150 MG) works by inhibiting platelet aggregation to prevent the formation of blood clots in arteries.

• Clopidogrel (75 MG) complements this action by blocking the P2Y12 receptor on platelets, further reducing the risk of clot formation.

This fixed-dose combination is commonly prescribed in both primary and secondary prevention of atherosclerotic complications and is a cornerstone therapy in post-cardiac event care.